Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Esperion Therapeutics Inc

ESPR
Current price
1.56 USD +0.01 USD (+0.65%)
Last closed 1.54 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 163 753 920 USD
Yield for 12 month -79.03 %
Week
Month
Year
ESPR
21.11.2021 - 28.11.2021

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Address: 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108

Analytics

WallStreet Target Price

8.25 USD

P/E ratio

Dividend Yield

Current Year

+75 475 000 USD

Last Year

+78 447 000 USD

Current Quarter

+33 969 000 USD

Last Quarter

+25 786 000 USD

Current Year

+48 508 000 USD

Last Year

+64 230 000 USD

Current Quarter

+20 592 000 USD

Last Quarter

+19 000 000 USD

Key Figures ESPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -155 459 008 USD
Operating Margin TTM -81.05 %
PE Ratio
Return On Assets TTM -36.44 %
PEG Ratio -4.78
Return On Equity TTM -260.79 %
Wall Street Target Price 8.25 USD
Revenue TTM 102 902 000 USD
Book Value -3.66 USD
Revenue Per Share TTM 1.1 USD
Dividend Share
Quarterly Revenue Growth YOY 79 %
Dividend Yield
Gross Profit TTM -70 419 000 USD
Earnings Share -2.27 USD
Diluted Eps TTM -2.27 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin -202.51 %

Dividend Analytics ESPR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ESPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:6
Payout Ratio
Last Split Date 11.06.2013
Dividend Date

Stock Valuation ESPR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 0.8819
Enterprise Value Revenue 3.0312
Price Sales TTM 1.5914
Enterprise Value EBITDA -2.0809
Price Book MRQ 98.4236

Financials ESPR

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ESPR

For 52 weeks

0.7 USD 8.87 USD
50 Day MA 0.98 USD
Shares Short Prior Month 18 218 864
200 Day MA 1.71 USD
Short Ratio 5.39
Shares Short 18 306 254
Short Percent 19.4 %